Relevant concomitant care permitted or prohibited during the trial {11d)
hypertension
HYPERTENSION
For the intervention period (weeks 1–8), we will use a constrained usual care model (requesting participants to keep antihypertensive medications constant if possible) to reduce non-study-related variability in the acute intervention phase. For the maintenance and no intervention periods (months 2–12), we will track the medication changes at study assessments but will not require participants to remain at a consistent dose. This plan is based upon current hypertension guidelines that allow for lifestyle interventions for 3–6 months in elevated/stage I hypertension. Both groups will receive written instructions reminding them to follow up as recommended with primary care.